Just seven countries accounted for more than 50 percent of global pharmaceutical growth in 2009, according to IMS Health. New business models are needed to succeed there.
(Dec 10, 2009)To succeed in Brazil, find the right partner, the right product mix, and the right pricing. Rajesh Chhabara reports.
(Feb 25, 2010)Continuing the eyeforpharma series on pharmerging markets, Rajesh Chhabara investigates why Russia remains a major opportunity, despite its many challenges.
(Apr 19, 2010)Rajesh Chhabara reports on how increased political stability, a growing population, and rising education levels are creating an emerging pharma market in the Middle East.
(May 18, 2010)*Multinational pharma firms need local networks of collaboration and discovery to succeed in India. Rajesh Chhabara reports*
(Nov 9, 2010)*Rajesh Chhabara reports on the challenges and opportunities in the South Korean pharma market*
(Feb 14, 2011)Rajesh Chhabara reports on how increased political stability, a growing population, and rising education levels are creating an emerging pharma market in the Middle East.
(Jun 27, 2011)Kevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs